Print this page
Long Term Follow Up for Subjects Treated with Gene Therapy Cell Products at Rutgers Cancer Institute.
The purpose of this protocol is to conduct long-term follow up of subjects who participate in gene therapy clinical trials at Rutgers Cancer Institute.
Protocol Number:
192103
Phase:
N/A
Applicable Disease Sites:
Any Site
Principal Investigator:
Christian Hinrichs
Scope:
Local
Participating Institutions:
- Rutgers Cancer Institute of New Jersey
For further information about clinical trials, please contact us at 732-235-7356.